Colorectal cancer (CRC) is the fourth most common cancer in the United States. The most common site of hematogenous spread is the liver. Nearly 50% of patients with CRC will eventually develop hepatic metastasis as part of their disease process.
This focus issue led by Dr. Mark E Reeves from Loma Linda University is dedicated to the surgical treatment of colorectal cancer hepatic metastasis. Experts in the field offer their perspectives about the important concepts, techniques, details, and practical “pearls” that make surgical resection of hepatic metastasis an important part of the armamentarium of the colorectal cancer disease management team.
Disclosure:
The series “Surgical Treatment of Colorectal Cancer Hepatic Metastasis” was commissioned by the editorial office, Journal of Gastrointestinal Oncology without any sponsorship or funding. Mark E Reeves served as the unpaid Guest Editor for the series.